INDUSTRY NEWS New Study Demonstrates Effectiveness of Prochymal as a Rescue Therapy for Pediatric Patients with Severe Graft vs. Host Disease Osiris Therapeutics, Inc. reported that a new study shows Prochymal achieved an overall response rate of 63% when used as a rescue therapy in children suffering from severe treatment resistant graft vs. host disease. [Osiris Therapeutics, Inc. Press Release] Investigators Present Phase III Data for Prochymal in Steroid-Refractory Graft vs. Host Disease Osiris Therapeutics, Inc. announced that results from the Phase III trial evaluating Prochymal for the treatment of steroid-refractory acute graft vs. host disease will be presented by Paul Martin, M.D., of the Fred Hutchinson Cancer Research Center and Paul Szabolcs, M.D., of Duke University Medical Center at the 2010 Blood and Marrow Transplant Tandem Meeting. [Osiris Therapeutics, Inc. Press Release] Merck KGaA and Millipore Announce Transaction Merck KGaA and Millipore Corporation recently announced that they have entered into a definitive agreement under which Merck KGaA will acquire all outstanding shares of common stock of Millipore, for US$107 per share in cash, or a total transaction value, including net debt, of approximately US$7.2 billion. [Merck KGaA Press Release] Startup Joins University of California, Los Angeles Tech Incubator to Develop Technologies for Drug Discovery, Screening Librede Inc. has joined the University of California, Los Angeles on-campus technology incubator space at the California NanoSystems Institute, where the startup company will work on developing technologies to improve ion channel drug discovery and screening. [California NanoSystems Institute Press Release] Aastrom Reports Interim Results from Critical Limb Ischemia Trial Aastrom Biosciences, Inc. reported results from a planned interim analysis of the company’s multi-center, randomized, double-blind, placebo-controlled U.S. Phase IIb clinical trial designated RESTORE-CLI. [Aastrom Biosciences, Inc. Press Release] $1.9 Billion in Research to Focus on Protecting Soldiers The Army’s fiscal 2011 science and technology budget that recently went forward for approval tops out at $1.9 billion and includes funding for advanced medical and force-protection research efforts. [United States Army Press Release] Oklahoma Tobacco Settlement Endowment Trust Provides $5.5 Million in Seed Money for Adult Stem Cell Research The Board of Directors of the Oklahoma Tobacco Settlement Endowment Trust during its quarterly meeting approved a proposal creating a virtual research center to be known as the Oklahoma Center for Adult Stem Cell Research. [Oklahoma Tobacco Settlement Endowment Trust Press Release] Stempeutics to Launch Its Stem Cell Based New Drug in India by 2012 Stempeutics Research is all set to introduce its investigational new drug in India by 2012. The drug is being developed in India for acute myocardial infarction and critical limb ischemia. [PharmaBiz Press Release]
|
|
POLICY NEWS National Institutes of Health Director Goes Shopping Francis Collins, the new leader of National Institutes of Health, announced that he will spend more than $200 million out of the Common Fund over the next five years on seven programmes in areas ranging from global health to how to speed therapies to the clinic. [National Institutes of Health, United States] Massachusetts Life Sciences Center Awards $6.6 Million Grant for Next Phase of Development at Gateway Park The Massachusetts Life Sciences Center Board of Directors recently awarded a $6.6 million grant to Worcester Polytechnic Institute to support the next phase of life sciences related development at Gateway Park in Worcester. [Massachusetts Life Sciences Center, United States] Massachusetts Life Sciences Center Launches 2010 Accelerator Program for Early-Stage Companies The primary objective of the Accelerator Loan Program is to provide working capital to early stage life sciences companies that still are in the process of further developing their science/technology and have not yet raised more than $5 million in equity financing. [Massachusetts Life Sciences Center, United States] Agency Information Collection Activities; Proposals, Submissions, and Approvals; Human Tissue Intended for Transplantation, 9226-9227 [FDA-2010-N-0066] [Food and Drug Administration, United States] National Institute of Arthritis and Musculoskeletal and Skin Diseases Accelerating Research Translation in Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine Competitive Revision Award (R01) (RFA-AR-11-004) [National Institute of Arthritis and Musculoskeletal and Skin Diseases, United States] National Institute of Arthritis and Musculoskeletal and Skin Diseases Accelerating Research Translation in Musculoskeletal and Skin Tissue Engineering and Regenerative Medicine Competitive Revision Award (P01 and P50) (RFA-AR-11-005) [National Institute of Arthritis and Musculoskeletal and Skin Diseases, United States] Cross Organ Mechanism-Associated Phenotypes for Genetic Analyses of Heart, Lung, Blood, and Sleep Diseases (MAPGen for HLBS) Research Centers (U01) (RFA-HL-11-005) [National Heart, Lung, and Blood Institute, United States] National Heart, Lung, and Blood Institute Will Provide Limited Supplemental Support to the National Institute of General Medical Sciences Medical Scientist Training Program in FY 2010 (NOT-HL-11-103) [National Heart, Lung, and Blood Institute, United States] 2010 Meeting Materials, Vaccines and Related Biological Products Advisory Committee Meeting – Draft Agenda, Member Roster [Food and Drug Administration, United States] Notice from the John E. Fogarty International Center with Corrections Made to PAR-10-065: Independent Scientist in Global Health Award (ISGHA) (K02) (NOT-TW-10-002) [National Institutes of Health, United States] Advancing Regulatory Science through Novel Research and Science-Based Technologies (U01) (RFA-RM-10-006) [National Institutes of Health, United States] Review Considerations for Applications and Awards under the New National Institutes of Health Guidelines for Human Stem Cell Research (NOT-OD-10-056) [National Institutes of Health, United States] UPDATE TO RFA-OD-10-009: OS Recovery Act Limited Competition: Methodology Development in Comparative Effectiveness Research (RC4) – Announcement of Non-Applicability of Requirement to Attend Meetings (NOT-OD-10-062) [National Institutes of Health, United States] Delays in Grant Application Submission to AHRQ due to Recent Winter Storm (NOT-HS-10-013) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral MD/PhD and Other Dual Doctoral Degree Fellows (Parent F30) (PA-10-107) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellows (Parent F31) (PA-10-108) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards for Individual Predoctoral Fellowships to Promote Diversity in Health-Related Research (Parent F31 – Diversity) (PA-10-109) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Postdoctoral Fellows (Parent F32) (PA-10-110) [National Institutes of Health, United States] Ruth L. Kirschstein National Research Service Awards (NRSA) for Individual Senior Fellows (Parent F33) (PA-10-111) [National Institutes of Health, United States] Notice of Intent to Establish a New National Institutes of Health Common Fund Program: Library of Integrated Network-Based Cellular Signatures (LINCS) (NOT-RM-10-002) [National Institutes of Health, United States] Expressions of Interest for Membership of the Therapeutic Goods Committee [Therapeutic Goods Administration, Australia]
|
|
EVENTS 36th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) March 21-24, 2010 Vienna, Austria 9th Transgenic Technology (TT) Meeting March 22-24, 2010 Berlin, Germany 4th United Kingdom Mesenchymal Stem Cell Meeting April 14, 2010 Leeds, United Kingdom World Stem Cells & Regenerative Medicine Congress 2010 May 11-13, 2010 London, United Kingdom 16th International Society for Cellular Therapy (ISCT) Meeting May 23-26, 2010 Philadelphia, United States International Society for Stem Cell Research (ISSCR) 8th Annual Meeting June 16-19, 2010 San Francisco, United States 5th World Congress on Preventative and Regenerative Medicine (WCRM) 2010 October 5-7, 2010 Hannover, Germany 2010 American Society for Matrix Biology (ASMB) Meeting October 24-27, 2010 Charleston, United States
JOB OPPORTUNITIES
Research & Development Technologist (STEMCELL Technologies)
Manufacturing Sciences Technologist – Cell Culture (STEMCELL Technologies) Reach more than 11,000 potential candidates by posting your organization’s career opportunities with Mesenchymal Cell News. Visit here to post your career opportunities.
Have we missed an important article or publication in Mesenchymal Cell News? Click here to submit!
|
| |
|